<DOC>
	<DOCNO>NCT02029053</DOCNO>
	<brief_summary>This pilot study , assess ability safety use VR101 intravaginal ring relieve symptom vaginal dryness , peri post-menopausal woman . VR1010 design release glycerol . The study assess duration lubrication/ moisturization vagina VR101 intravaginal ring place ( 7 day ) participant satisfaction device . Study participant insert intravaginal ring leave place initial 7 day repeat process 2nd time . Participants respond questionnaire , complete daily diary come 4 separate study visit . Each study visit involve brief vaginal exam . Upon removal initially inserted device ( 7 day first study visit ) , participant insert second device additional 7 day undergo evaluation .</brief_summary>
	<brief_title>Preliminary Study Vaginal Lubrication Ring Treat Symptoms Vaginal Dryness</brief_title>
	<detailed_description>Vaginal dryness affect many woman , although frequently bring topic doctor . Vaginal dryness dramatically affect woman 's lifestyle , particular sexual activity relationship partner . Since believe live uncomfortable vaginal dryness part age , intend conduct study evaluate lubricate vaginal ring develop ease symptom cause vaginal dryness . The objective study obtain preliminary data ability VR101 intravaginal ring relieve symptom vaginal dryness peri- post-menopausal woman . Effectiveness measure two way : 1 . Vaginal health index score assessed member research team 2 . Participant answer questionnaire Study objectives assess following : 1 . Successful placement VR101 intravaginal ring vagina 2 . Ease insertion removal 3 . Comfort fit 4 . Lubrication/ moisturization vagina</detailed_description>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<criteria>Signed informed consent Females 35 year age time enrollment Willing comply study visit schedule Selfreported peri postmenopausal woman selfreported vaginal dryness Willing abstain vaginal intercourse study Use hormone therapy Undergoing vulvar vaginal procedure ( biopsy , radiation last 3 month ) Active vulvar vaginal injections/lesions complaint , well undiagnosed abnormal genital bleed History chronic pelvic pain , interstitial cystitis , vulvar vestibulitis , pelvic inflammatory disease within past 12 week Known current clinically evident cervical vaginal infection Postpartum postabortion endometritis , unless symptom resolve least 12 week prior study entry Current persistent , abnormal vaginal bleeding History inability place IVR History abnormality vagina result distortion vaginal canal incompatible IVR placement Body habitus , history lower genital tract abnormality prior surgery , may allow vagina appropriately access Known suspect allergy hypersensitivity polyurethane glycerol Known current alcohol illicit drug abuse Participants recover adverse event due chemotherapy radiation treatment cancer Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Any condition , opinion investigator study staff would constitute contraindication participation study would compromise ability comply study protocol</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Vaginal dryness</keyword>
	<keyword>Vaginal lubrication</keyword>
	<keyword>Post-menopausal symptom</keyword>
	<keyword>Peri-menopausal symptom</keyword>
	<keyword>Urogenital atrophy</keyword>
	<keyword>Dyspareunia</keyword>
	<keyword>Painful intercourse</keyword>
</DOC>